- cafead   Jul 24, 2024 at 11:42: AM
via Blue Earth Therapeutics has entered a clinical research partnership with University College London in the UK to progress the clinical development of an Alpha-labelled Radioligand Therapy (RLT) for prostate cancer.
article source
article source